{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:32:44Z","timestamp":1778049164278,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Jilin Province Science and Technology Development Plan","award":["20160101051JC"],"award-info":[{"award-number":["20160101051JC"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s12253-019-00777-z","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T15:15:49Z","timestamp":1576163749000},"page":"1893-1901","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-0000","authenticated-orcid":false,"given":"Le","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"777_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262","journal-title":"CA Cancer J Clin"},{"key":"777_CR2","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","volume":"387","author":"M Chua","year":"2016","unstructured":"Chua M, Wee J, Hui EP, Chan A (2016) Nasopharyngeal carcinoma. Lancet 387:1012\u20131024. https:\/\/doi.org\/10.1016\/S0140-6736(15)00055-0","journal-title":"Lancet"},{"key":"777_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fonc.2018.00211","volume":"8","author":"MK Smatti","year":"2018","unstructured":"Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK (2018) Epstein-Barr virus epidemiology, serology, and genetic variability of LMP-1 Oncogene among healthy population: an update. Front Oncol 8:211. https:\/\/doi.org\/10.3389\/fonc.2018.00211","journal-title":"Front Oncol"},{"key":"777_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199509143331103","volume":"333","author":"R Pathmanathan","year":"1995","unstructured":"Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693\u2013698. https:\/\/doi.org\/10.1056\/NEJM199509143331103","journal-title":"N Engl J Med"},{"key":"777_CR5","first-page":"376","volume":"21","author":"D Liebowitz","year":"1994","unstructured":"Liebowitz D (1994) Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin Oncol 21:376\u2013381","journal-title":"Semin Oncol"},{"key":"777_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/path.4448","volume":"235","author":"SW Tsao","year":"2015","unstructured":"Tsao SW, Tsang CM, To KF, Lo KW (2015) The role of Epstein-Barr virus in epithelial malignancies. J Pathol 235:323\u2013333. https:\/\/doi.org\/10.1002\/path.4448","journal-title":"J Pathol"},{"key":"777_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejca.2017.02.029","volume":"77","author":"X Zou","year":"2017","unstructured":"Zou X, You R, Liu H et al (2017) Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment. Eur J Cancer 77:117\u2013126. https:\/\/doi.org\/10.1016\/j.ejca.2017.02.029","journal-title":"Eur J Cancer"},{"key":"777_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.canlet.2010.08.019","volume":"305","author":"GS Taylor","year":"2011","unstructured":"Taylor GS, Blackbourn DJ (2011) Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV. Cancer Lett 305:263\u2013278. https:\/\/doi.org\/10.1016\/j.canlet.2010.08.019","journal-title":"Cancer Lett"},{"key":"777_CR9","unstructured":"Young LS, Arrand JR, Murray PG (2007) EBV gene expression and regulation. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Chapter 27. Cambridge University Press, Cambridge"},{"key":"777_CR10","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1056\/NEJMoa032260","volume":"350","author":"JC Lin","year":"2004","unstructured":"Lin JC, Wang WY, Chen KY et al (2004) Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 350:2461\u20132470. https:\/\/doi.org\/10.1056\/NEJMoa032260","journal-title":"N Engl J Med"},{"key":"777_CR11","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1093\/jnci\/94.21.1614","volume":"94","author":"AT Chan","year":"2002","unstructured":"Chan AT, Lo YM, Zee B et al (2002) Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 94:1614\u20131619","journal-title":"J Natl Cancer Inst"},{"key":"777_CR12","doi-asserted-by":"publisher","unstructured":"Chan A, Hui EP, Ngan R et al (2018) Analysis of plasma Epstein-Barr virus DNA in nasopharyngeal Cancer after Chemoradiation to identify high-risk patients for adjuvant chemotherapy: a randomized controlled trial. J Clin Oncol: O2018777847. https:\/\/doi.org\/10.1200\/JCO.2018.77.7847","DOI":"10.1200\/JCO.2018.77.7847"},{"key":"777_CR13","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.ijrobp.2007.02.012","volume":"68","author":"JC Lin","year":"2007","unstructured":"Lin JC, Wang WY, Liang WM et al (2007) Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 68:1342\u20131348. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.02.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"777_CR14","doi-asserted-by":"publisher","first-page":"12613","DOI":"10.1128\/JVI.78.22.12613-12624.2004","volume":"78","author":"DM Pegtel","year":"2004","unstructured":"Pegtel DM, Middeldorp J, Thorley-Lawson DA (2004) Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J Virol 78:12613\u201312624. https:\/\/doi.org\/10.1128\/JVI.78.22.12613-12624.2004","journal-title":"J Virol"},{"key":"777_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/modpathol.3800369","volume":"18","author":"SD Hudnall","year":"2005","unstructured":"Hudnall SD, Ge Y, Wei L, Yang NP, Wang HQ, Chen T (2005) Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 18:519\u2013527. https:\/\/doi.org\/10.1038\/modpathol.3800369","journal-title":"Mod Pathol"},{"key":"777_CR16","doi-asserted-by":"publisher","first-page":"7749","DOI":"10.1128\/JVI.00108-09","volume":"83","author":"C Shannon-Lowe","year":"2009","unstructured":"Shannon-Lowe C, Adland E, Bell AI, Delecluse HJ, Rickinson AB, Rowe M (2009) Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol 83:7749\u20137760. https:\/\/doi.org\/10.1128\/JVI.00108-09","journal-title":"J Virol"},{"key":"777_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0002-9440(10)65157-7","volume":"155","author":"Q Tao","year":"1999","unstructured":"Tao Q, Swinnen LJ, Yang J, Srivastava G, Robertson KD, Ambinder RF (1999) Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. Am J Pathol 155:619\u2013625. https:\/\/doi.org\/10.1016\/S0002-9440(10)65157-7","journal-title":"Am J Pathol"},{"key":"777_CR18","first-page":"2612","volume":"8","author":"JH Tong","year":"2002","unstructured":"Tong JH, Tsang RK, Lo KW et al (2002) Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Clin Cancer Res 8:2612\u20132619","journal-title":"Clin Cancer Res"},{"key":"777_CR19","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1128\/JVI.02104-08","volume":"83","author":"K Cosmopoulos","year":"2009","unstructured":"Cosmopoulos K, Pegtel M, Hawkins J et al (2009) Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 83:2357\u20132367. https:\/\/doi.org\/10.1128\/JVI.02104-08","journal-title":"J Virol"},{"key":"777_CR20","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1128\/JVI.66.5.2689-2697.1992","volume":"66","author":"L Brooks","year":"1992","unstructured":"Brooks L, Yao QY, Rickinson AB, Young LS (1992) Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66:2689\u20132697","journal-title":"J Virol"},{"key":"777_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/jrr\/rrw128","volume":"58","author":"A Prayongrat","year":"2017","unstructured":"Prayongrat A, Chakkabat C, Kannarunimit D, Hansasuta P, Lertbutsayanukul C (2017) Prevalence and significance of plasma Epstein-Barr virus DNA level in nasopharyngeal carcinoma. J Radiat Res 58:509\u2013516. https:\/\/doi.org\/10.1093\/jrr\/rrw128","journal-title":"J Radiat Res"},{"key":"777_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2478\/raon-2018-0016","volume":"52","author":"C Lertbutsayanukul","year":"2018","unstructured":"Lertbutsayanukul C, Kannarunimit D, Prayongrat A, Chakkabat C, Kitpanit S, Hansasuta P (2018) Prognostic value of plasma EBV DNA for nasopharyngeal Cancer patients during treatment with intensity-modulated radiation therapy and concurrent chemotherapy. Radiol Oncol 52:195\u2013203. https:\/\/doi.org\/10.2478\/raon-2018-0016","journal-title":"Radiol Oncol"},{"key":"777_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1128\/JVI.69.2.675-683.1995","volume":"69","author":"KM Kaye","year":"1995","unstructured":"Kaye KM, Izumi KM, Mosialos G, Kieff E (1995) The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues. J Virol 69:675\u2013683","journal-title":"J Virol"},{"key":"777_CR24","first-page":"549","volume":"10","author":"DS Huen","year":"1995","unstructured":"Huen DS, Henderson SA, Croom-Carter D, Rowe M (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549\u2013560","journal-title":"Oncogene"},{"key":"777_CR25","doi-asserted-by":"publisher","first-page":"27328","DOI":"10.18632\/oncotarget.16033","volume":"8","author":"A Turunen","year":"2017","unstructured":"Turunen A, Rautava J, Grenman R, Syrjanen K, Syrjanen S (2017) Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas. Oncotarget 8:27328\u201327338. https:\/\/doi.org\/10.18632\/oncotarget.16033","journal-title":"Oncotarget"},{"key":"777_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hed.10039","volume":"24","author":"Y Chang","year":"2002","unstructured":"Chang Y, Cheng SD, Tsai CH (2002) Chromosomal integration of Epstein-Barr virus genomes in nasopharyngeal carcinoma cells. Head Neck 24:143\u2013150","journal-title":"Head Neck"},{"key":"777_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/260302a0","volume":"260","author":"C Kaschka-Dierich","year":"1976","unstructured":"Kaschka-Dierich C, Adams A, Lindahl T et al (1976) Intracellular forms of Epstein-Barr virus DNA in human tumour cells in vivo. Nature 260:302\u2013306","journal-title":"Nature"},{"key":"777_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrc2375","volume":"8","author":"K Pantel","year":"2008","unstructured":"Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329\u2013340. https:\/\/doi.org\/10.1038\/nrc2375","journal-title":"Nat Rev Cancer"},{"key":"777_CR29","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1373\/clinchem.2011.165068","volume":"57","author":"ES Lianidou","year":"2011","unstructured":"Lianidou ES, Markou A (2011) Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin Chem 57:1242\u20131255. https:\/\/doi.org\/10.1373\/clinchem.2011.165068","journal-title":"Clin Chem"},{"key":"777_CR30","first-page":"27","volume":"292","author":"SJ Stevens","year":"2005","unstructured":"Stevens SJ, Brink AA, Middeldorp JM (2005) Profiling of Epstein-Barr virus latent RNA expression in clinical specimens by gene-specific multiprimed cDNA synthesis and PCR. Methods Mol Biol 292:27\u201338","journal-title":"Methods Mol Biol"},{"key":"777_CR31","doi-asserted-by":"publisher","first-page":"C50","DOI":"10.1152\/ajpcell.1983.244.1.C50","volume":"244","author":"JH Pavlovitch","year":"1983","unstructured":"Pavlovitch JH, Didierjean L, Rizk M, Balsan S, Saurat JH (1983) Skin calcium-binding protein: distribution in other tissues. Am J Phys 244:C50\u2013C57. https:\/\/doi.org\/10.1152\/ajpcell.1983.244.1.C50","journal-title":"Am J Phys"},{"key":"777_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ijc.30418","volume":"140","author":"O Ramayanti","year":"2017","unstructured":"Ramayanti O, Juwana H, Verkuijlen SA et al (2017) Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin. Int J Cancer 140:149\u2013162. https:\/\/doi.org\/10.1002\/ijc.30418","journal-title":"Int J Cancer"},{"key":"777_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2019.01.022","volume":"447","author":"YJ Xu","year":"2019","unstructured":"Xu YJ, Zhou R, Zong JF et al (2019) Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2\/NF-kappaB pathway. Cancer Lett 447:33\u201340. https:\/\/doi.org\/10.1016\/j.canlet.2019.01.022","journal-title":"Cancer Lett"},{"key":"777_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41389-017-0005-7","volume":"6","author":"LL Zuo","year":"2017","unstructured":"Zuo LL, Zhang J, Liu LZ et al (2017) Cadherin 6 is activated by Epstein-Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma. Oncogenesis 6:402. https:\/\/doi.org\/10.1038\/s41389-017-0005-7","journal-title":"Oncogenesis"},{"key":"777_CR35","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1158\/0008-5472.CAN-16-2706","volume":"77","author":"D Huang","year":"2017","unstructured":"Huang D, Song SJ, Wu ZZ et al (2017) Epstein-Barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages. Cancer Res 77:3591\u20133604. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2706","journal-title":"Cancer Res"},{"key":"777_CR36","doi-asserted-by":"publisher","first-page":"6951","DOI":"10.26355\/eurrev_201908_18735","volume":"23","author":"XQ Xie","year":"2019","unstructured":"Xie XQ, Luo Y, Ma XL et al (2019) Clinical significance of circulating tumor cells and their expression of cyclooxygenase-2 in patients with nasopharyngeal carcinoma. Eur Rev Med Pharmacol Sci 23:6951\u20136961. https:\/\/doi.org\/10.26355\/eurrev_201908_18735","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"777_CR37","doi-asserted-by":"publisher","first-page":"111509","DOI":"10.1016\/j.bios.2019.111509","volume":"142","author":"SW Lee","year":"2019","unstructured":"Lee SW, Chen YW, Kuan EC, Lan MY (2019) Dual-function nanostructured platform for isolation of nasopharyngeal carcinoma circulating tumor cells and EBV DNA detection. Biosens Bioelectron 142:111509. https:\/\/doi.org\/10.1016\/j.bios.2019.111509","journal-title":"Biosens Bioelectron"},{"key":"777_CR38","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/ijc.32380","volume":"145","author":"R You","year":"2019","unstructured":"You R, Liu YP, Lin M et al (2019) Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients. Int J Cancer 145:2873\u20132883. https:\/\/doi.org\/10.1002\/ijc.32380","journal-title":"Int J Cancer"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-019-00777-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T01:02:53Z","timestamp":1607648573000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-019-00777-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1007\/s12253-019-00777-z","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"2 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The Authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}